ATRC - AtriCure, Inc.
NEXT EARNINGS:
Apr 27, 2026
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$50.67
DETAILS
HIGH:
$55.00
LOW:
$44.00
MEDIAN:
$53.00
CONSENSUS:
$50.67
UPSIDE:
62.72%
Market Cap:
1.55B
Volume:
867,656
Avg Volume:
622,846
52 Week Range:
28.29-43.18
Sector:
Healthcare
Industry:
Medical - Instruments & Supplies
Beta:
1.41
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
1,300
IPO Date:
2005-08-05
EPS (TTM):
-0.24
P/E Ratio:
-165.01
Revenue (TTM):
534.53M
Total Assets:
654.18M
Total Debt:
88.02M
Cash & Equiv:
167.43M
Rev Growth (5Y):
21.0%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-0.6%
Debt/Equity:
0.18
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-17 | $0.04 | $-0.04 | +200.0% | $140.5M | $139.8M | +0.5% |
| 2025-10-29 | $-0.01 | $-0.11 | +90.9% | $134.3M | $140.5M | -4.4% |
| 2025-07-29 | $-0.02 | $-0.15 | +86.7% | $136.1M | $130.1M | +4.6% |
| 2025-04-29 | $-0.14 | $-0.25 | +44.0% | $123.6M | $130.6M | -5.3% |
| 2025-02-12 | $-0.08 | $-0.23 | +65.2% | $124.3M | $121.8M | +2.0% |
| 2024-10-29 | $-0.17 | $-0.20 | +15.0% | $115.9M | $119.8M | -3.3% |
| 2024-07-30 | $-0.17 | $-0.15 | -13.3% | $116.3M | $116.2M | 0.0% |
| 2024-05-01 | $-0.25 | $-0.21 | -19.0% | $108.9M | $106.9M | +1.8% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 534.53M | 465.31M | 399.25M | 330.38M | 274.33M | 206.53M | 230.81M | 201.63M | 174.72M | 155.11M | 129.75M | 107.45M |
| Net Income | (11.45M) | (44.70M) | (30.44M) | (46.47M) | 50.20M | (48.16M) | (35.19M) | (21.14M) | (26.89M) | (33.34M) | (27.21M) | (16.21M) |
| EPS | -0.24 | -0.95 | -0.66 | -1.02 | 1.11 | -1.14 | -0.94 | -0.62 | -0.83 | -1.05 | -0.97 | -0.61 |
| Total Assets | 654.18M | 609.33M | 613.93M | 585.45M | 615.31M | 714.54M | 557.88M | 356.76M | 267.70M | 276.42M | 273.09M | 158.40M |
| Total Debt | 88.02M | 76.53M | 74.49M | 74.55M | 75.65M | 74.00M | 76.42M | 52.46M | 37.42M | 38.89M | 14.16M | 4.05M |
| Cash & Equivalents | 167.43M | 122.72M | 84.31M | 58.10M | 43.65M | 41.94M | 28.48M | 32.23M | 21.81M | 24.21M | 23.76M | 28.38M |
| Operating Cash Flow | 57.33M | 12.20M | 4.48M | (22.14M) | (13.78M) | (19.87M) | (15.81M) | (4.17M) | (8.94M) | (15.12M) | (7.84M) | (21.60M) |
| Free Cash Flow | 48.28M | (11.26M) | (37.51M) | (39.02M) | (23.53M) | (25.13M) | (27.99M) | (10.38M) | (15.33M) | (22.81M) | (31.84M) | (30.81M) |
| FCF per Share | 1.01 | -0.24 | -0.81 | -0.85 | -0.52 | -0.60 | -0.74 | -0.30 | -0.47 | -0.72 | -1.13 | -1.17 |
| Book Value | 491.94M | 460.97M | 466.17M | 456.75M | 483.76M | 412.39M | 247.34M | 249.38M | 161.17M | 168.44M | 186.69M | 132.54M |
| Cash & ST Investments | 167.43M | 122.72M | 137.28M | 121.11M | 119.09M | 244.22M | 81.80M | 124.40M | 34.45M | 44.01M | 34.58M | 59.65M |
| ROC Equity | -0.02 | -0.10 | -0.07 | -0.10 | 0.10 | -0.12 | -0.14 | -0.08 | -0.17 | -0.20 | -0.15 | -0.12 |